Table 1.
Characteristics of Study Group
| Parameter | Number of Persons (%) Who Were Primed with Two Doses of BNT162B2 (n=114) | Number of Persons (%) Who Were Primed with Two Doses of ChAdOx1-S (n=78) |
|---|---|---|
| Age, years | ||
| ≤50 | 48 (42%) | 27 (31%) |
| >50 | 66 (58%) | 51 (69%) |
| Sex | ||
| Female | 84 (74%) | 57 (73%) |
| Male | 30 (26%) | 21(27%) |
| History of COVID-19 | ||
| Present | 60 (53%) | 57 (73%) |
| Absent | 54 (47%) | 21(27%) |
| BMI, kg/m2 | ||
| ≤ 24.9 | 66 (58%) | 30 (38%) |
| >24.9 | 48 (42%) | 48 (62%) |
| Other diseases | ||
| Present | 69 (60%) | 48 (62%) |
| Absent | 45 (40%) | 30 (38%) |
| Post-vaccination symptoms | ||
| Present | 57 (50%) | 51 (65%) |
| Absent | 57 (50%) | 27 (35%) |